Seaman Pro/Seaman
Semen Analysis Device. 510(k) K252228, from Checkcells, Inc. (Santa Monica, CA). Product code POV, class 2.
As of Nov 18, 2026, K252228 is an FDA 510(k) held by Checkcells, Inc., substantially equivalent on Apr 9, 2026 after 267 days, with no recalls tied to it in FDA's recall database.
- Review time: 267 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe Seaman PRO Analyzer is an automated, point-of-care, in vitro use-only medical device for semen analysis performed by healthcare professionals. The desktop unit consists of a light source, optical elements, and an image sensor connected to a PC, which records a video of the semen sample and sends it to the cloud compute unit.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- LensHooke X1 Pro Semen Quality Analyzer, LensHooke X1 Semen Quality AnalyzerK180343 · Bonraybio Co., Ltd. · Nov 16, 2018
Other POV clearances
The newest 510(k)s for the same product code; their median review was 270 days; see every POV device- LensHooke X3 PRO Semen Quality Analyzer; LensHooke X3 PRO SE Semen Quality AnalyzerK242830 · Bonraybio Co., Ltd. · May 30, 2025
- LensHooke X12 PRO Semen Analysis SystemK242388 · Bonraybio Co., Ltd. · May 9, 2025
- YO Home Sperm TestK241628 · Medical Electronic Systems , Ltd. · Nov 29, 2024
- SQA-iO Sperm Quality AnalyzerK220828 · Medical Electronic Systems , Ltd. · Aug 7, 2023
Elsewhere
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 16, 2025
- Review panel
- Hematology
- Regulation
- 21 CFR 864.5220
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files